What usage claims can PTD-DBM currently support?
Can describe the specifications and research directions to be verified in the catalog, but cannot thereby provide a definite promise of effects in humans or animals. No. Same target does not mean the chemical entities are the same; competitive peptides, lipid-modified derivatives, and small molecules should be verified separately, and related hair growth mechanism data cannot be equated to human hair growth trials.
: Not allowed. Sharing the same target does not mean the chemical entity is the same; competitive peptides, lipid-modified derivatives, and small molecules should be verified separately, and related hair mechanism data cannot be equated to human hair growth trials. This page is a compilation of purpose-oriented positive data, not a systematic review or dosing recommendation. Historical studies, combined preparations, and special models are individually marked.
Qualified direct in vivo main literature has not yet been screened
: Not allowed. Sharing the same target does not mean the chemical entity is the same; competitive peptides, lipid-modified derivatives, and small molecules should be verified separately, and related hair mechanism data cannot be equated to human hair growth trials.
See common questions about this product ↓References
Supplement background1 article · not included in main in vivo literature
The following information is used to explain mechanisms, material identity, or evidence boundaries and cannot replace direct in vivo validation of the same product, formulation, and use.
What is the connection between CXXC5 competitive peptide and hair regeneration mechanisms?
PTD-DBM competitive peptide promotes hair regeneration and wound-induced hair follicle neogenesis.[1] ↗
PubMed index Review; abstract includes experiments on mouse hair growth and human dermal papilla cells
2017; marked as Review in database, original in vivo main listing not counted for now; human part is isolated cells, not human scalp test.
View the Article Title and Full Citation＋
Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis.
The Journal of Investigative Dermatology · Volume, Issue, Year 2017
First published 2017-06-06 · PMID 28595998
DOI 10.1016/j.jid.2017.04.038
Direct in vivo primary literature has not been included in this round; research status is mentioned above.
Common issues and corresponding evidence
PTD-DBM can directly use the small molecule CXXC5 inhibitor paper?＋
: Not allowed. Sharing the same target does not mean the chemical entity is the same; competitive peptides, lipid-modified derivatives, and small molecules should be verified separately, and related hair mechanism data cannot be equated to human hair growth trials.[1] ↗
PTD-DBM Why aren’t 3–5 efficacy papers listed?＋
At this stage, no sufficient qualified original studies have been screened that simultaneously correspond to commercial identity, main research purpose, and intervention form. Papers with similar names, single components, or other purposes cannot be used to supplement the data.
Current status of data / procurement verification, not efficacy conclusions.What materials are needed when reviewing PTD-DBM study materials?＋
The full name, CAS or sequence, modifications/salt form, component ratio, source, and SKU batch COA should first be verified, then compared item by item with the paper materials.
Current status of data / procurement verification, not efficacy conclusions.PTD-DBM
Return to catalog specifications and batch file verification entry.
